Effect of anti-TNF- tumor necrosis factor therapy on lipid profile in a sample of patients attending Baghdad teaching hospital | ||
| IRAQI JOURNALOF COMMUNITY MEDICINE | ||
| Article 1, Volume 29, Issue 2, June 2016, Pages 16-20 | ||
| Authors | ||
| Nazar Abdull Latif; Ali Hussein; Atta AH Mousa | ||
| Abstract | ||
| Background: Anti-tumor necrosis factor drugs (biological agents) are a class of drugs that are used worldwide to treat inflammatory conditions “these drugs are able to reduce inflammation and stop disease progression”. Objectives: To evaluate lipid profile changes after anti-TNF therapy in patients with psoriatic, rheumatoid arthritis and ankylosing spondylitis Patients &methods: A prospective study included 90 patients presenting with 30 Psoriatic arthritis (n=30), ankylosing spondylitis (n=30) rheumatoid arthritis (n=30) who were treated with anti-TNF therapy (infliximab, rituxmab etanercept) and assessed during follow-up period after 6month of therapy. Results: Regarding lipid profile, significance differences (P<0.000) were seen after biological therapy with infliximab infusion in patients with psoriatic arthritis. The current study had significant differences regarding TG and HDL after 6 month of treatment of rheumatoid arthritis patients with rituximab., Significance differences were seen regarding TG and LDL in ankylosing spondylitis patients treated with etanercept Conclusion: Significance differences were seen regarding lipid profile and antitumor necrosis factor alpha therapy regarding psoriatic, Rheumatoid arthritis and ankylosing spondylitis | ||
| Keywords | ||
| Dyslipidemia; Psoriatic arthritis; Rheumatoid arthritis; AntiTNF | ||
|
Statistics Article View: 202 PDF Download: 70 |
||